A new class of weight-loss drugs is changing the food industry, but not in the way many expected at first. They could present just as many opportunities as pitfalls. People taking the drugs do indeed eat less—especially indulgent treats.

Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known about their long-term effects

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.

A mong the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking remedies for erectile dysfunction and hair loss. Since May it has offered its own version of Wegovy,

Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and 2023, a new tally finds. "In contrast, there was a 25.6% decrease in patients undergoing metabolic bariatric surgery" during the same time period,

Meds like Wegovy are all over the news. But are they right for you, especially if you're older than the average user?By Hallie LevineAre you wondering whether you’re a candidate for one of the